Horses 1 to 2 mL Dogs and Cats 0.25 to 0.5 mL May be repeated once or twice a week, as indicated by the condition and response of the animal
California made headlines in 2024 by announcing plans to expand Medi-Cal coverage to include GLP-1 medications for obesity, a significant policy shift that puts California ahead of virtually every other state on this issue
Rotate injection sites between uses to prevent local irritation or lipodystrophy
And the next 5 to 10 years, youre going to see paradigm shifts in how psychiatric is going to be treated, without question
By working collaboratively across the ecosystem, we help ensure that consumers have access to safe and effective solutions and medications. The End of the GLP-1 Shortage In October 2024, the FDA announced that the shortage of tirzepatide, the active ingredient in Mounjaro and Zepbound, was resolved, and shortages of other GLP-1s are also poised to be resolved in the near future